Market Place
Sourcing Support
Galapagos Shareholders Approve All 2026 Meeting Resolutions
28 Apr 2026 //
FIRSTWORD PHARMA
Galapagos, Gilead Partner On 1st-In-Class T Cell Engager Program
31 Mar 2026 //
GLOBENEWSWIRE
Galapagos Publishes 2025 Annual Report, Calls Shareholder Meeting
26 Mar 2026 //
GLOBENEWSWIRE
Galapagos Announces Nomination of Gino to Board of Directors
26 Mar 2026 //
GLOBENEWSWIRE
Galapagos Receives Transparency Notification From Bank Of America
17 Mar 2026 //
GLOBENEWSWIRE
Galapagos Gets Transparency Notifications From Bank Of America
10 Mar 2026 //
GLOBENEWSWIRE
Galapagos Creates New Subscription Right Plan
06 Mar 2026 //
GLOBENEWSWIRE
Galapagos Appoints Tania Philipp As Chief Human Resources Officer
05 Mar 2026 //
GLOBENEWSWIRE
Galapagos Receives Transparency from Bank of America
04 Mar 2026 //
GLOBENEWSWIRE
Galapagos Unveils 2025 Financials, Fourth Quarter Business Update
23 Feb 2026 //
GLOBENEWSWIRE
Galapagos Welcomes Dr. Paulo Fontoura To Its Board Of Directors
19 Feb 2026 //
GLOBENEWSWIRE
Galapagos Receives Transparency Notification From Bank Of America
16 Feb 2026 //
GLOBENEWSWIRE
Galapagos Receive Transparency Notifications from Bank of America
10 Feb 2026 //
GLOBENEWSWIRE
Galapagos Gets Transparency Notifications From Bank Of America
26 Nov 2025 //
GLOBENEWSWIRE
Galapagos Reports 9-Month 2025 Financials & Business Update
05 Nov 2025 //
GLOBENEWSWIRE
Galapagos Board Revamped To Boost Business Development Focus
30 Oct 2025 //
GLOBENEWSWIRE
Galapagos Appoints Fred Blakeslee As General Counsel
16 Oct 2025 //
GLOBENEWSWIRE
Galapagos Creates New Subscription Right Plan
07 Aug 2025 //
GLOBENEWSWIRE
Galapagos Gets Fda Rmat for Glpg5101 in Mantle Cell Lymphoma
06 Aug 2025 //
GLOBENEWSWIRE
Galapagos Appoints Executives Svoronos and Griffiths to Board
23 Jul 2025 //
GLOBENEWSWIRE
Galapagos Add Life Science Execs to Boost Business Transformation
23 Jul 2025 //
GLOBENEWSWIRE
Galapagos Reports Strong Financial Results, Updates on Q2
23 Jul 2025 //
GLOBENEWSWIRE
Galapagos Appoints Aaron Cox as Chief Financial Officer
23 Jun 2025 //
GLOBENEWSWIRE
Galapagos Creates New Subscription Right Plan
27 May 2025 //
GLOBENEWSWIRE
Galapagos Announces Strategic Update on Separation, Leadership
13 May 2025 //
GLOBENEWSWIRE
Galapagos Reports Q1 2025 Financial Results & Highlights
23 Apr 2025 //
GLOBENEWSWIRE
Galapagos Announces Executive Leadership Updates
21 Apr 2025 //
GLOBENEWSWIRE
Galapagos CFO and COO Thad Huston to Depart on August 1, 2025
15 Apr 2025 //
GLOBENEWSWIRE
Galapagos Publishes 2024 Annual Report, Announces Meeting
27 Mar 2025 //
GLOBENEWSWIRE
Galapagos to Present at Upcoming Investor Conferences
24 Feb 2025 //
GLOBENEWSWIRE
Galapagos Gets Transparency Notification, 13D Filing From Tang
17 Feb 2025 //
GLOBENEWSWIRE
Galapagos splits in 2, laying off 40% of staff
08 Jan 2025 //
FIERCE BIOTECH
Galapagos to Present at the 43rd Annual J.P. Morgan Conference
07 Jan 2025 //
GLOBENEWSWIRE
Galapagos Reports Q3 2024 Financial Results & Business Update
30 Oct 2024 //
GLOBENEWSWIRE
Galapagos receives transparency notification from EcoR1 Capital
30 Sep 2024 //
GLOBENEWSWIRE
Galapagos receives transparency notification from FMR LLC
03 Sep 2024 //
GLOBENEWSWIRE
Galapagos Investor Signals Intent To Influence Undervalued Company
26 Aug 2024 //
FIERCE BIOTECH
Galapagos Gets FDA Clearance For Phase 1/2 CAR-T Study In Lymphoma
23 Aug 2024 //
GLOBENEWSWIRE
Galapagos receives transparency notification from FMR LLC
20 Aug 2024 //
GLOBENEWSWIRE
Galapagos Reports H1 2024 Results And Q2 Business Update
01 Aug 2024 //
GLOBENEWSWIRE
BridGene And Galapagos Expand Collaboration On SMARCA2 PROTAC
01 Aug 2024 //
PR NEWSWIRE
Galapagos Presents GLPG5101 NHL Data At EHA 2024
14 Jun 2024 //
GLOBENEWSWIRE
Erasca restructures; Novartis moves to complete MorphoSys deal
17 May 2024 //
BIOPHARMADIVE
Galapagos creates new subscription right plans
16 May 2024 //
GLOBENEWSWIRE
Galapagos bolsters decentralized CAR-T manufacturing
16 May 2024 //
GLOBENEWSWIRE
Galapagos, Blood Centers Collaborate On Decentralized US CAR-T Manufacturing
15 May 2024 //
GLOBENEWSWIRE
Galapagos reports first quarter 2024 financial results
02 May 2024 //
GLOBENEWSWIRE
Galapagos™ Shareholders Adopt Board`s Resolutions At Meetings
30 Apr 2024 //
GLOBENEWSWIRE
Galapagos Shows Innovative Approach in Hematological Cancer Data at EBMT
04 Apr 2024 //
GLOBENEWSWIRE
Galapagos Publishes 2023 Annual Report and Announces Annual Meetings
28 Mar 2024 //
GLOBENEWSWIRE
Galapagos appoints Dickinson as Non-Executive independent Director to its Board
26 Mar 2024 //
GLOBENEWSWIRE
Galapagos halts lupus CAR-T work, confirms 100 layoffs this year
24 Feb 2024 //
FIERCE BIOTECH
Galapagos announces full year 2023 results and outlook for 2024
22 Feb 2024 //
GLOBENEWSWIRE
Galapagos presents at EBMT-EHA annual meeting 2024
15 Feb 2024 //
GLOBENEWSWIRE
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
31 Jan 2024 //
GLOBENEWSWIRE
Galapagos enters into collaboration agreement with Thermo Fisher Scientific
04 Jan 2024 //
GLOBENEWSWIRE
Galapagos Collaborates With BridGene Biosciences To Develop Cancer Treatments
04 Jan 2024 //
YAHOO FINANCE
BridGene Biosciences Announces Strategic Collaboration with Galapagos
03 Jan 2024 //
PR NEWSWIRE
Galapagos establishes strategic collaboration with BridGene Biosciences
03 Jan 2024 //
GLOBENEWSWIRE
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
02 Jan 2024 //
GLOBENEWSWIRE
